triptorelin

(redirected from Gonapeptyl)
Also found in: Wikipedia.

triptorelin

 [trip″to-rel´in]
a synthetic analogue of gonadorelin that on prolonged administration suppresses gonadotropin release; used as triptorelin pamoate as an antineoplastic in the palliative treatment of prostatic carcinoma, administered intramuscularly.

triptorelin

/trip·to·rel·in/ (trip″to-rel´in) a synthetic gonadorelin analogue that on prolonged administration suppresses gonadotropin release; used as t. pamoate as an antineoplastic in the treatment of prostatic carcinoma.

triptorelin

a gonadotropin-releasing hormone used to treat advanced prostate cancer.

triptorelin

Therapeutics A long-acting gonadotropin-releasing hormone analogue, that induces intense reversible hypogonadism by inhibiting LH and, to a lesser degree, FSH release, resulting in ↓ testosterone Indications Advanced prostate and ovarian CA; it may have a role in Rx-refractory sexual deviancy. See Paraphilia.

triptorelin

A synthetic gonadotrophin-releasing hormone used to treat advances cancer of the PROSTATE GLAND. A brand name is Decapeptyl SR.
References in periodicals archive ?
16 Sales Forecast for Trelstar, Decapeptyl, Gonapeptyl, Flutamide, Estradiol 81
Figure 48: Prostate Cancer, US, Combined sales of Trelstar, Decapeptyl, Gonapeptyl, Flutamide, Estradiol, Sales Forecast ($m), 2001-2020 90
Figure 42: Prostate Cancer, Spain, Combined sales of Trelstar, Decapeptyl, Gonapeptyl, Flutamide, Estradiol, Sales Forecast ($m), 2001-2020 82
Figure 42: Prostate Cancer, Japan, Combined sales of Trelstar, Decapeptyl, Gonapeptyl, Flutamide, Estradiol, Sales Forecast ($m), 2001-2020 79
Figure 42: Prostate Cancer, France, Combined sales of Trelstar, Decapeptyl, Gonapeptyl, Flutamide, Estradiol, Sales Forecast ($m), 2001-2020 80
Figure 42: Prostate Cancer, Germany, Combined sales of Trelstar, Decapeptyl, Gonapeptyl, Flutamide, Estradiol, Sales Forecast ($m), 2001-2020 76
Figure 51: Prostate Cancer, US, Combined sales of Trelstar, Decapeptyl, Gonapeptyl, Flutamide, Estradiol, Sales Forecast ($m), 2001-2020